

A practical guide for healthcare providers on helping patients locate Macrobid during the 2026 shortage. Tools, workflow tips, and prescribing strategies.
When you prescribe Nitrofurantoin (Macrobid) for a UTI in 2026, there's a real chance your patient will call back saying the pharmacy is out of stock. The ongoing Macrobid shortage means that providers need practical strategies — not just clinical alternatives, but actionable tools to help patients get treated quickly.
This guide focuses on the operational side: how to integrate shortage awareness into your prescribing workflow and connect patients with the resources they need.
The Nitrofurantoin shortage is not a total stockout. Macrobid is still being manufactured and shipped, but availability is inconsistent. A pharmacy that was out of stock yesterday may have a shipment today, and vice versa. This means the key challenge is matching patients to pharmacies that have current inventory.
For a detailed overview of the clinical and supply factors driving the shortage, see our companion article: Macrobid shortage: What providers and prescribers need to know in 2026.
The most impactful thing you can do is tell patients about the shortage before they leave your office. A simple statement makes a significant difference:
"I'm prescribing Nitrofurantoin for your UTI. There's been a national shortage, so your usual pharmacy may not have it in stock. If they don't, here are some options..."
This prevents the frustrating cycle of patient-calls-pharmacy-calls-office-calls-patient that wastes everyone's time.
MedFinder is a free tool that helps patients (and providers) find pharmacies with specific medications in stock. Here's how to integrate it into your workflow:
When a patient calls saying their pharmacy doesn't have Macrobid:
For efficiency during the shortage, consider developing a standardized approach for UTI prescribing when Nitrofurantoin is unavailable:
| If the patient... | Consider... |
|---|---|
| Has no drug allergies | TMP-SMX 160/800 mg BID × 3 days (if local resistance <20%) |
| Has sulfa allergy | Fosfomycin 3 g single dose or Cephalexin 500 mg BID × 7 days |
| Is pregnant | Cephalexin 500 mg BID × 7 days or Amoxicillin-clavulanate 500/125 mg BID × 7 days |
| Has recurrent UTIs | Culture-guided therapy; consider Methenamine hippurate 1 g BID for prophylaxis |
| Has penicillin allergy | TMP-SMX or Fosfomycin (avoid cephalosporins if severe allergy) |
Some practices have found success adding conditional notes to prescriptions:
"Rx: Nitrofurantoin mono/macro 100 mg, #14, Sig: 1 cap BID × 7 days. If unavailable, please contact office for alternative. Patient aware of shortage."
This signals to the pharmacist that the prescriber is aware of the shortage and ready to act quickly if needed.
Always prescribe as "Nitrofurantoin monohydrate/macrocrystals" or "Nitrofurantoin" rather than "Macrobid" to allow pharmacists maximum flexibility in dispensing.
Check the "substitution permitted" box. This allows pharmacists to dispense any manufacturer's product and any equivalent formulation.
If your patient can take Macrodantin (Nitrofurantoin macrocrystals), it may be more available. Remember to adjust dosing: Macrodantin is typically 50-100 mg QID rather than Macrobid's 100 mg BID.
For patients on prophylactic Nitrofurantoin, mail-order pharmacies (Amazon Pharmacy, Cost Plus Drugs, insurance mail-order benefits) may have better access to consistent supply. Suggest this for maintenance prescriptions.
Make sure everyone in your practice knows about the shortage:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.